Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

PCV10 Reactogenicity and Immunogenicity Study - Malindi (PRISM)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2010 by KEMRI-Wellcome Trust Collaborative Research Program.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborators:
Kenya Ministry of Health
University of Oxford
University of Colorado, Denver
GlaxoSmithKline
Information provided by:
KEMRI-Wellcome Trust Collaborative Research Program
ClinicalTrials.gov Identifier:
NCT01028326
First received: December 7, 2009
Last updated: August 23, 2010
Last verified: August 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: March 2011
  Estimated Primary Completion Date: September 2010 (Final data collection date for primary outcome measure)
No publications provided by KEMRI-Wellcome Trust Collaborative Research Program

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):